TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis

Journal of Histochemistry and Cytochemistry

Volumn 64, Issue 3, 2016, Pages 157-167

  Xu, Fengyun ^a   Liu, Changwei ^a   Zhou, Dandan ^a   Zhang, Lei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial myofibroblast transition; hepatic fibrosis; miRNAs; TGF SMAD

Indexed keywords

COLLAGEN TYPE 1; LONG UNTRANSLATED RNA; MICRORNA; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA;

CELL TRANSFORMATION; EPITHELIAL MYOFIBROBLAST TRANSITION; EXTRACELLULAR MATRIX; FIBROGENESIS; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; HUMAN; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

HUMANS; LIVER CIRRHOSIS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84959374130     PISSN: 00221554     EISSN: 15515044     Source Type: Journal    
DOI: 10.1369/0022155415627681     Document Type: Review

References (107)

1. F.AldehniM.SpitznerJ.R.MartinsR.Barro-SoriaR.SchreiberK.Kunzelmann (2009). Bestrophin 1 promotes epithelial-to-mesenchymal transition of renal collecting duct cells. J Am Soc Nephrol20:1556-1564.
2. M.AzumaK.MotegiK.AotaT.YamashitaH.YoshidaM.Sato (1999). TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1. Exp Cell Res250:213-222.
3. S.BalaM.MarcosK.KodysT.CsakD.CatalanoP.MandrekarG.Szabo (2011). Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem286:1436-1444.
4. S.BalaG.Szabo (2012). MicroRNA Signature in Alcoholic Liver Disease. Int J Hepatol2012:498232.
5. E.A.BarnesH.L.KenersonX.JiangR.S.Yeung (2010). Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition. Am J Pathol177:1765-1778.
6. R.BatallerD.A.Brenner (2005). Liver fibrosis. J Clin Invest115:209-218.
7. W.R.BiG.T.XuL.X.LvC.Q.Yang (2014). The ratio of transforming growth factor-beta1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis. Genet Mol Res13:1005-1014.
8. W.R.BiC.Q.YangQ.Shi (2012). Transforming growth factor-beta1 induced epithelial-mesenchymal transition in hepatic fibrosis. Hepatogastroenterology59:1960-1963.
9. E.B.BianC.HuangH.WangX.X.ChenL.ZhangX.W.LvJ.Li (2014). Repression of Smad7 mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats. Toxicol Lett224:175-185.
10. M.Blanco CalvoV.Bolos FernandezV.Medina VillaamilG.Aparicio GallegoS.Diaz PradoE.Grande Pulido (2009). Biology of BMP signalling and cancer. Clin Transl Oncol11:126-137.
11. U.BlankS.Karlsson (2011). The role of Smad signaling in hematopoiesis and translational hematology. Leukemia25:1379-1388.
12. M.R.BoonG.van der HorstG.van der PluijmJ.T.TamsmaJ.W.SmitP.C.Rensen (2011). Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency. Cytokine Growth Factor Rev22:221-229.
13. W.A.BorderN.A.Noble (1998). Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int54:1390-1391.
14. A.ConidiS.CazzolaK.BeetsK.CoddensC.CollartF.CornelisL.CoxD.JokeM.P.DobrevaR.DriesC.EsguerraA.FrancisA.IbrahimiR.KroesF.LesageE.MaasI.MoyaP.N.PereiraE.StappersA.StryjewskaV.van den BergheL.VermeireG.VerstappenE.SeuntjensL.UmansA.ZwijsenD.Huylebroeck (2011). Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFbeta/BMP signaling in vivo. Cytokine Growth Factor Rev22:287-300.
15. M.B.DattoJ.P.FrederickL.PanA.J.BortonY.ZhuangX.F.Wang (1999). Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol19:2495-2504.
16. R.DerynckY.E.Zhang (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature425:577-584.
17. P.DongiovanniS.RomeoL.Valenti (2014). Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. World J Gastroenterol20:12945-12955.
18. S.DooleyJ.HamzaviL.CiuclanP.GodoyI.IlkavetsS.EhnertE.UeberhamR.GebhardtS.KanzlerA.GeierK.BreitkopfH.WengP.R.Mertens (2008). Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology135:642-659.
19. S.DooleyM.StreckertB.DelvouxA.M.Gressner (2001). Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun283:554-562.
20. Y.DrabschP.ten Dijke (2012). TGF-beta signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev31:553-568.
21. J.DudasI.KovalszkyM.GallaiJ.O.NagyZ.SchaffT.KnittelM.MehdeK.NeubauerF.SzalayG.Ramadori (2001). Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. Am J Clin Pathol115:725-735.
22. K.M.EddingtonF.DolcosR.CabezaR.KRRKT.J.Strauman (2007). Neural correlates of promotion and prevention goal activation: an fMRI study using an idiographic approach. J Cogn Neurosci19:1152-1162.
23. S.L.Friedman (2008). Mechanisms of hepatic fibrogenesis. Gastroenterology134:1655-1669.
24. S.L.Friedman (2004). Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol1:98-105.
25. H.FukasawaT.YamamotoA.TogawaN.OhashiY.FujigakiT.OdaC.UchidaK.KitagawaT.HattoriS.SuzukiM.KitagawaA.Hishida (2004). Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A101:8687-8692.
26. B.GaoR.Bataller (2011). Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology141:1572-1585.
27. A.GentiliniF.MarraP.GentiliniM.Pinzani (2000). Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. J Hepatol32:227-234.
28. R.GovindenK.D.Bhoola (2003). Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther98:257-265.
29. A.M.GressnerR.Weiskirchen (2006). Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med10:76-99.
30. J.HamzaviS.EhnertP.GodoyL.CiuclanH.WengP.R.MertensR.HeuchelS.Dooley (2008). Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice. J Cell Mol Med12:2130-2144.
31. Y.HeC.HuangX.SunX.-R.LongX.-W.LvJ.Li (2012). MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal24:1923-1930.
32. E.L.HeinrichT.C.WalserK.KrysanE.L.LiclicanJ.L.GrantN.L.RodriguezS.M.Dubinett (2012). The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron5:5-18.
33. J.HeyerD.Escalante-AlcaldeM.LiaE.BoettingerW.EdelmannC.L.StewartR.Kucherlapati (1999). Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc Natl Acad Sci U S A96:12595-12600.
34. K.A.HruskaG.GuoM.WozniakD.MartinS.MillerH.LiapisK.LovedayS.KlahrT.K.SampathJ.Morrissey (2000). Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol279:F130-143.
35. C.F.HuangC.C.SunF.ZhaoY.D.ZhangD.J.Li (2015). miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol. 50:480-490.
36. S.M.KaX.R.HuangH.Y.LanP.Y.TsaiS.M.YangH.A.ShuiA.Chen (2007). Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol18:1777-1788.
37. S.M.KaY.C.YehX.R.HuangT.K.ChaoY.J.HungC.P.YuT.J.LinC.C.WuH.Y.LanA.Chen (2012). Kidney-targeting Smad7 gene transfer inhibits renal TGF-beta/MAD homologue (SMAD) and nuclear factor kappaB (NF-kappaB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia55:509-519.
38. R.KalluriR.A.Weinberg (2009). The basics of epithelial-mesenchymal transition. J Clin Invest119:1420-1428.
39. J.S.KangE.F.SaunierR.J.AkhurstR.Derynck (2008). The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol10:654-664.
40. S.KanzlerA.W.LohseA.KeilJ.HenningerH.P.DienesP.SchirmacherS.Rose-JohnK.H.zum BuschenfeldeM.Blessing (1999). TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol276:G1059-1068.
41. P.KavsakR.K.RasmussenC.G.CausingS.BonniH.ZhuG.H.ThomsenJ.L.Wrana (2000). Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell6: 1366-1375.
42. H.Y.Lan (2003). Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens12:25-29.
43. H.Y.LanA.C.Chung (2012). TGF-beta/Smad signaling in kidney disease. Semin Nephrol32:236-243.
44. H.Y.LanA.C.Chung (2011). Transforming growth factor-beta and Smads. Contrib Nephrol170:75-82.
45. G.LatellaA.VetuschiR.SferraV.CatittiA.D’AngeloG.ZanninelliK.C.FlandersE.Gaudio (2009). Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int29:997-1009.
46. J.G.LeeE.P.Kay (2012). NF-kappaB is the transcription factor for FGF-2 that causes endothelial mesenchymal transformation in cornea. Invest Ophthalmol Vis Sci53:1530-1538.
47. U.E.LeeS.L.Friedman (2011). Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol25:195-206.
48. X.LinM.LiangX.H.Feng (2000). Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem275:36818-36822.
49. H.MariboE.V.OlsenP.J.Barton-GadeA.Møller (1998). Comparison of dehiding versus scalding and singeing: effect on temperature, pH and meat quality in pigs. Meat Sci50:175-189.
50. R.T.MarquezS.BandyopadhyayE.B.WendlandtK.KeckB.A.HofferM.S.IcardiR.N.ChristensenW.N.SchmidtA.P.McCaffrey (2010). Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest90:1727-1736.
51. J.MassagueD.Wotton (2000). Transcriptional control by the TGF-beta/Smad signaling system. EMBO J19:1745-1754.
52. A.MassziA.Kapus (2011). Smaddening complexity: the role of Smad3 in epithelial-myofibroblast transition. Cells Tissues Organs193:41-52.
53. A.I.MedeirosA.Sa-NunesE.G.SoaresC.M.PeresC.L.SilvaL.H.Faccioli (2004). Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect Immun72:1637-1644.
54. X.M.MengA.C.ChungH.Y.Lan (2013). Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond)124:243-254.
55. X.M.MengX.R.HuangA.C.ChungW.QinX.ShaoP.IgarashiW.JuE.P.BottingerH.Y.Lan (2010). Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol21:1477-1487.
56. X.M.MengX.R.HuangJ.XiaoA.C.ChungW.QinH.Y.ChenH.Y.Lan (2012). Disruption of Smad4 impairs TGF-beta/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int81:266-279.
57. A.MoustakasS.SouchelnytskyiC.H.Heldin (2001). Smad regulation in TGF-beta signal transduction. J Cell Sci114:4359-4369.
58. Y.MurakamiH.ToyodaM.TanakaM.KurodaY.HaradaF.MatsudaA.TajimaN.KosakaT.OchiyaK.Shimotohno (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One6:e16081.
59. E.P.NadlerD.PattersonS.VioletteP.WeinrebM.LewisM.S.MagidM.A.Greco (2009). Integrin alphavbeta6 and mediators of extracellular matrix deposition are up-regulated in experimental biliary atresia. J Surg Res154:21-29.
60. R.NgG.SongG.R.RollN.M.FrandsenH.Willenbring (2012). A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest122:1097-1108.
61. Y.Y.NgC.C.HouW.WangX.R.HuangH.Y.Lan (2005). Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl:S83-91.
62. G.PagesP.LenormandG.L’AllemainJ.C.ChambardS.MelocheJ.Pouyssegur (1993). Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A90:8319-8323.
63. C.PanH.ChenL.WangS.YangH.FuY.ZhengM.MiaoB.Jiao (2012). Down-regulation of MiR-127 facilitates hepatocyte proliferation during rat liver regeneration. PLoS One7:e39151.
64. M.K.PhanishN.A.WahabP.Colville-NashB.M.HendryM.E.Dockrell (2006). The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J393:601-607.
65. H.QiangY.LinX.ZhangX.ZengJ.ShiY.X.ChenM.F.YangZ.G.HanW.F.Xie (2006). Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver Int26:1126-1137.
66. T.E.QuanS.E.CowperR.Bucala (2006). The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep8:145-150.
67. S.RossC.S.Hill (2008). How the Smads regulate transcription. Int J Biochem Cell Biol40:383-408.
68. K.A.RygielH.RobertsonH.L.MarshallM.PekalskiL.ZhaoT.A.BoothD.E.JonesA.D.BurtJ.A.Kirby (2008). Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest88:112-123.
69. M.SatoY.MuragakiS.SaikaA.B.RobertsA.Ooshima (2003). Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest112:1486-1494.
70. B.SchnablC.A.BradhamB.L.BennettA.M.ManningB.StefanovicD.A.Brenner (2001). TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology34:953-963.
71. M.SchreiberA.KolbusF.PiuA.SzabowskiU.Möhle-SteinleinJ.TianM.KarinP.AngelE.F.Wagner (1999). Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev13:607-619.
72. U.SenguptaS.UkilN.DimitrovaS.Agrawal (2009). Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications. PLoS One4:e8100.
73. F.W.ShekR.C.Benyon (2004). How can transforming growth factor beta be targeted usefully to combat liver fibrosis?Eur J Gastroenterol Hepatol16:123-126.
74. P.SinghJ.D.WigR.Srinivasan (2011). The Smad family and its role in pancreatic cancer. Indian J Cancer48:351-360.
75. R.SpizzoD.RushworthM.GuerreroG.A.Calin (2009). RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma9 Suppl 3:S313-318.
76. M.StopaD.AnhufL.TerstegenP.GatsiosA.M.GressnerS.Dooley (2000). Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem275:29308-29317.
77. W.K.SynY.JungA.OmenettiM.AbdelmalekC.D.GuyL.YangJ.WangR.P.WitekC.M.FearingT.A.PereiraV.TeaberryS.S.ChoiJ.Conde-VancellsG.F.KaracaA.M.Diehl (2009). Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology137:1478-1488 e1478.
78. P.SysaJ.J.PotterX.LiuE.Mezey (2009). Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol28:425-434.
79. G.SzaboS.Bala (2013). MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol10:542-552.
80. R.TanW.HeX.LinL.P.KissY.Liu (2008). Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication. Am J Physiol Renal Physiol294:F1076-1083.
81. S.TaoK.Sampath (2010). Alternative splicing of SMADs in differentiation and tissue homeostasis. Dev Growth Differ52:335-342.
82. E.W.ThompsonI.Haviv (2011). The social aspects of EMT-MET plasticity. Nat Med17:1048-1049.
83. Z.TianA.S.GreeneJ.L.PietruszI.R.MatusM.Liang (2008). MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res18:404-411.
84. M.TrojanowskaE.C.LeRoyB.EckesT.Krieg (1998). Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med (Berl)76:266-274.
85. K.TsuchidaY.ZhuS.SivaS.R.DunnK.Sharma (2003). Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells. Kidney Int63:2000-2009.
86. J.UittoD.Kouba (2000). Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci24 Suppl 1:S60-69.
87. F.VerrecchiaA.Mauviel (2004). TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. Cell Signal16:873-880.
88. B.WangP.KohC.WinbanksM.T.CoughlanA.McClellandA.WatsonK.Jandeleit-DahmW.C.BurnsM.C.ThomasM.E.CooperP.Kantharidis (2011). miR-200a Prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes60:280-287.
89. J.WangI.LeclercqJ.M.BrymoraN.XuM.Ramezani-MoghadamR.M.LondonD.BrigstockJ.George (2009). Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology137:713-723.
90. W.WangX.R.HuangA.G.LiF.LiuJ.H.LiL.D.TruongX.J.WangH.Y.Lan (2005a). Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol16:1371-1383.
91. W.WangV.KokaH.Y.Lan (2005b).Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton)10:48-56.
92. J.West (2010). Cross talk between Smad, MAPK, and actin in the etiology of pulmonary arterial hypertension. Adv Exp Med Biol661:265-278.
93. B.C.WillisR.M.duBoisZ.Borok (2006). Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc3:377-382.
94. F.XieZ.ZhangH.van DamL.ZhangF.Zhou (2014). Regulation of TGF-beta Superfamily Signaling by SMAD Mono-Ubiquitination. Cells3:981-993.
95. Y.C.YangE.PiekJ.ZavadilD.LiangD.XieJ.HeyerP.PavlidisR.KucherlapatiA.B.RobertsE.P.Bottinger (2003). Hierarchical model of gene regulation by transforming growth factor beta. Proc Natl Acad Sci U S A100:10269-10274.
96. Q.Y.YaoB.L.XuJ.Y.WangH.C.LiuS.C.ZhangC.T.Tu (2012). Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement Altern Med12:156.
97. E.M.ZeisbergS.E.PotentaH.SugimotoM.ZeisbergR.Kalluri (2008). Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol19:2282-2287.
98. E.M.ZeisbergO.TarnavskiM.ZeisbergA.L.DorfmanJ.R.McMullenE.GustafssonA.ChandrakerX.YuanW.T.PuA.B.RobertsE.G.NeilsonM.H.SayeghS.IzumoR.Kalluri (2007a). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med13:952-961.
99. M.ZeisbergR.Kalluri (2008). Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci13:6991-6998.
100. M.ZeisbergC.YangM.MartinoM.B.DuncanF.RiederH.TanjoreR.Kalluri (2007b). Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem282:23337-23347.
101. L.ZhangC.LiuX.M.MengC.HuangF.XuJ.Li (2015). Smad2 protects against TGF-beta1/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis. Mol Cell Biochem400:17-28.
102. Y.ZhangJ.WeiH.WangX.XueY.AnD.TangZ.YuanF.WangJ.WuJ.ZhangY.Miao (2012). Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer. Oncol Rep27:1599-1605.
103. J.ZhouW.JuD.WangL.WuX.ZhuZ.GuoX.He (2012). Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS One7:e33577.
104. Q.ZhouX.R.HuangJ.YuX.YuH.Y.Lan (2015). Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation. Mol Ther23:1034-1043.
105. D.ZhuX.HeY.DuanJ.ChenJ.WangX.SunH.QianJ.FengW.SunF.XuL.Zhang (2014). Expression of microRNA-454 in TGF-beta1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum. Parasit Vectors7:148.
106. H.J.ZhuA.M.Sizeland (1999). Smad7 Differentially Regulates Transforming Growth Factor b-mediated Signaling Pathways. J Biol Chem274:32258-32264.
107. L.ZhuL.WangX.WangX.LuoL.YangR.ZhangH.YinD.XieY.PanY.Chen (2011). Hepatic deletion of Smad7 in mouse leads to spontaneous liver dysfunction and aggravates alcoholic liver injury. PLoS One6:e17415.